Valuation: Hugel, Inc.

Market Cap 3,020B 2.13B 1.84B 1.72B 1.57B 2.97B 203B 3.01B 20.21B 7.93B 102B 8B 7.82B 338B P/E 2026 *
19.9x
P/E 2027 * 15.6x
Enterprise Value 2.46B 1.74M 1.5M 1.4M 1.28M 2.42M 166M 2.46M 16.47M 6.46M 82.81M 6.52M 6.37M 276M EV / Sales 2026 *
4.68x
EV / Sales 2027 * 3.62x
Free-Float
45.22%
Yield 2026 *
-
Yield 2027 * -
1 day+2.19%
1 week+16.95%
Current month+20.22%
1 month+16.22%
3 months-4.12%
6 months+7.50%
Current year+21.26%
1 week 254,000
Extreme 254000
295,000
1 month 216,500
Extreme 216500
295,000
Current year 216,500
Extreme 216500
308,500
1 year 208,500
Extreme 208500
353,500
3 years 106,400
Extreme 106400
392,000
5 years 99,700
Extreme 99700
392,000
10 years 75,865.91
Extreme 75865.908
392,000
Manager TitleAgeSince
Director of Finance/CFO 61 -
Chief Tech/Sci/R&D Officer 54 -
Chief Executive Officer 49 -
Director TitleAgeSince
Director/Board Member 54 29/04/2022
Director/Board Member 56 29/04/2022
Director/Board Member 51 29/04/2022
Date Insider Type Main position Quantity % Market Cap.
5/20/25 A Fiscal year 1,200 0.0095%
5/20/25 A Sell 1,200 0.0095%
5/19/25 A Fiscal year

Chairman

31,510 0.2500%
Change 5-day change 1-year change 3-year change Capi.($)
+2.19%+16.95%-22.14%+138.07% 2.13B
+3.02%+6.43%+43.53%+1.90% 80.69B
+0.84%+10.26%-0.15%+27.24% 51.22B
-0.04%+1.67%+22.01%+176.54% 49.58B
+2.87%+8.18%-48.46%-49.18% 45.5B
-0.39%+2.63%+58.51%-23.02% 30.6B
+0.82%+2.63%+55.06%+85.54% 24.64B
+1.08%+8.47%+128.98%-40.36% 23.88B
-1.59%+13.14%+6.63%+202.17% 21.59B
-0.09%+3.30%+65.10%+114.68% 16.48B
Average +1.21%+4.66%+30.91%+63.36% 34.63B
Weighted average by Cap. +1.43%+4.39%+28.26%+43.46%

Financials

2026 *2027 *
Net sales 526B 371M 321M 300M 274M 517M 35.36B 525M 3.52B 1.38B 17.69B 1.39B 1.36B 58.92B 639B 451M 390M 365M 333M 628M 43B 638M 4.28B 1.68B 21.51B 1.69B 1.66B 71.65B
Net income 171B 120M 104M 97.47M 89.09M 168M 11.49B 171M 1.14B 449M 5.75B 452M 442M 19.14B 220B 155M 134M 125M 115M 216M 14.79B 220M 1.47B 577M 7.4B 582M 570M 24.64B
Net Debt -559B -394M -341M -319M -291M -549M -37.58B -558M -3.74B -1.47B -18.8B -1.48B -1.45B -62.61B -705B -497M -430M -402M -367M -693M -47.39B -703M -4.72B -1.85B -23.71B -1.87B -1.83B -78.96B
Logo Hugel, Inc.
Hugel Inc is a Korea-based company mainly engaged in the manufacture and sale of biopharmaceutical products. The Company is mainly engaged in the research, development, manufacturing, and sales of biopharmaceuticals utilizing type A botulinum toxin derived from the microorganism clostridium botulinum, as well as hyaluronic acid–based tissue‑restoration biomaterial filler products. In addition, the Company sells botulinum toxin products, hyaluronic acid fillers, cosmetics, skin boosters, and lifting threads. The Company distributes its products in domestic and overseas markets.
Employees
604
Date Price Change Volume
10/08/26 ₩279,500.00 +2.19% 71,938
07/08/26 ₩273,500.00 -1.97% 96,138
06/08/26 ₩279,000.00 +7.31% 123,618
05/08/26 ₩260,000.00 +0.78% 38,984
04/08/26 ₩258,000.00 +7.95% 50,802
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
279,500.00KRW
Average target price
369,312.50KRW
Spread / Average Target
+32.13%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A145020 Stock